+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Skin Barrier Market by Shape and Surgery Type: Global Opportunity Analysis and Industry Forecast, 2019-2026

  • ID: 5118786
  • Report
  • April 2020
  • Region: Global
  • 145 Pages
  • Allied Analytics LLP

FEATURED COMPANIES

  • 3M Company
  • B. Braun Melsungen AG
  • Coloplast Corp
  • ConvaTec Group PLC
  • Hollister Inc.
  • Nu-Hope Laboratories Inc.
The global skin barriers market was valued at $868.1 million in 2018, and is expected to reach $1,191.5 million by 2026, registering a CAGR of 4.1% from 2019 to 2026. A skin barrier is used to manage the containment of stool, which is of liquid or semiliquid consistency. It is used in patients dealing with fecal incontinence and help them to keep the skin free from contaminants and moisture that may cause skin breakdown. It is a thin film attached to the ostomy pouches to prevent leakage of the body fluids. It helps in reduction of infection transmission by keeping infectious body waste contained in a closed system. Furthermore, it supports to protect the perianal and sacral pressure areas. Skin barriers or devices play a key role in minimizing the likelihood of involuntary bowel leakage and constipation.



The global skin barriers market is expected to witness significant growth during the forecast period majorly due to availability of technological advanced devices for bowel management. Furthermore, a rise in geriatric population and surge in fecal inconsistency-related disorders significantly contribute toward market growth. However, dearth of trained professionals and patient discomfort in using these devices hinder the growth of market. In addition, high cost of skin barriers and increase in risk of allergies due to skin barrier materials restrain market growth. On the contrary, the introduction of various new materials that offer more prevention of leakage and development of the healthcare R&D facilities are expected to offer lucrative opportunities for expansion of the global skin barriers market.

The global skin barriers market is segmented into shape, surgery type, and region. On the basis of shape, the market is divided into flat and convex. Depending on surgery type, it is classified into colostomy, ileostomy, and urostomy. Region wise, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA. Key players operating in skin barriers markets are 3M Company, B. Braun Melsungen AG, Coloplast Corp, ConvaTec Group PLC, Cymed Ostomy Pouching Systems, Hollister Inc., Marlen Manufacturing & Development Co., Nu-Hope Laboratories, Inc., Safe n’ Simple Medical, and Torbot Group, Inc.

KEY BENEFITS FOR STAKEHOLDERS
  • The study provides an in-depth analysis of the market along with the current trends and future estimations to elucidate the imminent investment pockets.
  • It offers a quantitative analysis from 2018 to 2026, which is expected to enable the stakeholders to capitalize on prevailing market opportunities.
  • Comprehensive analysis of all geographical regions is provided to determine the prevailing opportunities.
  • Key players are profiled, and their strategies are analyzed thoroughly to understand the competitive outlook of the global market.

KEY MARKET SEGMENTS

By Shape
  • Flat
  • Convex

By Drug Type
  • Colostomy
  • Ileostomy
  • Urostomy

By Region
  • North America
  • U.S.
  • Canada
  • Mexico
  • Europe
  • Germany
  • France
  • UK
  • Italy
  • Spain
  • Rest of Europe
  • Asia Pacific
  • Japan
  • China
  • India
  • Rest of Asia-Pacific
  • LAMEA
  • Brazil
  • Saudi Arabia
  • South Africa
  • Rest of LAMEA

LIST OF KEY PLAYERS PROFILED IN THE REPORT
  • 3M Company
  • B. Braun Melsungen AG
  • Coloplast Corp
  • ConvaTec Group PLC
  • Cymed Ostomy Pouching Systems
  • Hollister Inc.
  • Marlen Manufacturing & Development Co.
  • Nu-Hope Laboratories, Inc.
  • Safe n’ Simple Medical
  • Torbot Group, Inc.
Frequently Asked Questions about the Global Skin Barriers Market

What is the estimated value of the Global Skin Barriers Market?

The Global Skin Barriers Market was estimated to be valued at $868.1 million in 2018.

What is the growth rate of the Global Skin Barriers Market?

The growth rate of the Global Skin Barriers Market is 4.0%, with an estimated value of $1191.5 million by 2026.

What is the forecasted size of the Global Skin Barriers Market?

The Global Skin Barriers Market is estimated to be worth $1191.5 million by 2026.

Who are the key companies in the Global Skin Barriers Market?

Key companies in the Global Skin Barriers Market include 3M Company, B. Braun Melsungen AG, Coloplast Corp, ConvaTec Group PLC, Cymed Ostomy Pouching Systems, Hollister Inc., Marlen Manufacturing & Development Co., Nu and Safe n’ Simple Medical.
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • 3M Company
  • B. Braun Melsungen AG
  • Coloplast Corp
  • ConvaTec Group PLC
  • Hollister Inc.
  • Nu-Hope Laboratories Inc.

Chapter 1: Introduction
1.1. Report Description
1.2. Key Benefits for Stakeholders
1.3. Research Methodology
1.3.1. Secondary Research
1.3.2. Primary Research
1.3.3. Analyst Tools & Models
Chapter 2: Executive Summary
2.1. Cxo Perspective
Chapter 3: Market Overview
3.1. Market Definition and Scope
3.2. Porter’S Five Forces Analysis
3.3. Top Player Positioning
3.4. Market Dynamics
3.4.1. Drivers
3.4.1.1. Rise in Incidence of Irritable Bowel Syndrome
3.4.1.2. Surge in Geriatric Population Across the Globe
3.4.2. Restraint
3.4.2.1. Dearth of Trained Professionals
3.4.3. Opportunity
3.4.3.1. High Growth Potential in Emerging Economies
Chapter 4: Skin Barriers Market, by Shape
4.1. Overview
4.1.1. Market Size and Forecast
4.2. Flat-Shaped Skin Barriers
4.2.1. Key Market Trends and Opportunities
4.2.2. Market Size and Forecast
4.2.3. Market Analysis, by Country
4.3. Convex Skin Barriers
4.3.1. Key Trends and Opportunities
4.3.2. Market Size and Forecast
4.3.3. Market Analysis, by Country
Chapter 5: Skin Barriers Market, by Surgery Type
5.1. Overview
5.1.1. Market Size and Forecast
5.2. Colostomy
5.2.1. Market Size and Forecast
5.2.2. Market Analysis, by Country
5.3. Ileostomy
5.3.1. Market Size and Forecast
5.3.2. Market Analysis, by Country
5.4. Urostomy
5.4.1. Market Size and Forecast
5.4.2. Market Analysis, by Country
Chapter 6: Skin Barriers Market, by Region
6.1. Overview
6.1.1. Market Size and Forecast
6.2. North America
6.2.1. Key Trends and Opportunities
6.2.2. Market Size and Forecast, by Country
6.2.3. Market Size and Forecast, by Shape
6.2.4. Market Size and Forecast, by Surgery
6.2.5. U. S.
6.2.5.1. U. S. Market Size and Forecast, by Shape
6.2.5.2. U. S. Market Size and Forecast, by Surgery
6.2.6. Canada
6.2.6.1. Canada Market Size and Forecast, by Shape
6.2.6.2. Canada Market Size and Forecast, by Surgery
6.2.7. Mexico
6.2.7.1. Mexico Market Size and Forecast, by Shape
6.2.7.2. Mexico Market Size and Forecast, by Surgery
6.3. Europe
6.3.1. Key Trends and Opportunities
6.3.2. Europe Market Size and Forecast, by Country
6.3.3. Europe Market Size and Forecast, by Shape
6.3.4. Europe Market Size and Forecast, by Surgery
6.3.5. Germany
6.3.5.1. Germany Market Size and Forecast, by Shape
6.3.5.2. Germany Market Size and Forecast, by Surgery
6.3.6. UK
6.3.6.1. UK Market Size and Forecast, by Shape
6.3.6.2. UK Market Size and Forecast, by Surgery
6.3.7. Spain
6.3.7.1. Spain Market Size and Forecast, by Shape
6.3.7.2. Spain Market Size and Forecast, by Surgery
6.3.8. France
6.3.8.1. France Market Size and Forecast, by Shape
6.3.8.2. France Market Size and Forecast, by Surgery
6.3.9. Italy
6.3.9.1. Italy Market Size and Forecast, by Shape
6.3.9.2. Italy Market Size and Forecast, by Surgery
6.3.10. Rest of Europe
6.3.10.1. Rest of Europe Market Size and Forecast, by Shape
6.3.10.2. Rest of Europe Market Size and Forecast, by Surgery
6.4. Asia-Pacific
6.4.1. Key Trends and Opportunities
6.4.2. Asia-Pacific Market Size and Forecast, by Country
6.4.3. Asia-Pacific Market Size and Forecast, by Shape
6.4.4. Asia-Pacific Market Size and Forecast, by Surgery
6.4.5. Japan
6.4.5.1. Japan Market Size and Forecast, by Shape
6.4.5.2. Japan Market Size and Forecast, by Surgery
6.4.6. China
6.4.6.1. China Market Size and Forecast, by Shape
6.4.6.2. China Market Size and Forecast, by Surgery
6.4.7. India
6.4.7.1. India Market Size and Forecast, by Shape
6.4.7.2. India Market Size and Forecast, by Surgery
6.4.8. Australia
6.4.8.1. Australia Market Size and Forecast, by Shape
6.4.8.2. Australia Market Size and Forecast, by Surgery
6.4.9. Rest of Asia-Pacific
6.4.9.1. Rest of Asia-Pacific Market Size and Forecast, by Shape
6.4.9.2. Rest of Asia-Pacific Market Size and Forecast, by Surgery
6.5. LAMEA
6.5.1. Key Market Trends and Opportunities
6.5.2. LAMEA Market Size and Forecast, by Country
6.5.3. LAMEA Market Size and Forecast, by Shape
6.5.4. LAMEA Market Size and Forecast, by Surgery
6.5.5. Brazil
6.5.5.1. Brazil Market Size and Forecast, by Shape
6.5.5.2. Brazil Market Size and Forecast, by Surgery
6.5.6. South Africa
6.5.6.1. South Africa Market Size and Forecast, by Shape
6.5.6.2. South Africa Market Size and Forecast, by Surgery
6.5.7. Saudi Arabia
6.5.7.1. Saudi Arabia Market Size and Forecast, by Shape
6.5.7.2. Saudi Arabia Market Size and Forecast, by Surgery
6.5.8. Rest of LAMEA
6.5.8.1. Rest of LAMEA Market Size and Forecast, by Shape
6.5.8.2. Rest of LAMEA Market Size and Forecast, by Surgery
Chapter 7: Company Profiles
7.1.3M Company
7.1.1. Company Overview
7.1.2. Company Snapshot
7.1.3. Operating Business Segments
7.1.4. Product Portfolio
7.1.5. Business Performance
7.2. B. Braun Melsungen AG
7.2.1. Company Overview
7.2.2. Company Snapshot
7.2.3. Operating Business Segments
7.2.4. Product Portfolio
7.2.5. Business Performance
7.3. Coloplast Corp
7.3.1. Company Overview
7.3.2. Company Snapshot
7.3.3. Operating Business Segments
7.3.4. Product Portfolio
7.3.5. Business Performance
7.3.6. Key Strategic Moves and Developments
7.4. Convatech
7.4.1. Company Overview
7.4.2. Company Snapshot
7.4.3. Operating Business Segments
7.4.4. Product Portfolio
7.4.5. Business Performance
7.4.6. Key Strategic Moves and Developments
7.5. Cymed Ostomy Pouching Systems
7.5.1. Company Overview
7.5.2. Company Snapshot
7.5.3. Operating Business Segments
7.5.4. Product Portfolio
7.6. Hollister Inc.
7.6.1. Company Overview
7.6.2. Company Snapshot
7.6.3. Operating Business Segments
7.6.4. Product Portfolio
7.7. Marlen Manufacturing & Development Co.
7.7.1. Company Overview
7.7.2. Operating Business Segments
7.7.3. Product Portfolio
7.8. Nu-Hope Laboratories, Inc.
7.8.1. Company Overview
7.8.2. Company Snapshot
7.8.3. Operating Business Segments
7.8.4. Product Portfolio
7.9. Safe N’ Simple Medical
7.9.1. Company Overview
7.9.2. Company Snapshot
7.9.3. Operating Business Segments
7.9.4. Product Portfolio
7.10. Torbot Group, Inc.
7.10.1. Company Overview
7.10.2. Company Snapshot
7.10.3. Operating Business Segments
7.10.4. Product Portfolio
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • 3M Company
  • B. Braun Melsungen AG
  • Coloplast Corp
  • ConvaTec Group PLC
  • Hollister Inc.
  • Nu-Hope Laboratories Inc.
According to the report titled, 'Skin Barrier Market by Shape and Surgery Type: opportunity analysis and industry forecast, 2018-2026,” The skin barriers market size was valued at $868.1 million in 2018 and is expected to reach $1,191.5 million by 2026, registering a CAGR of 4.1% from 2019 to 2026. Skin barriers are used along with the ostomy pouches, which are used for the management of fecal inconsistency in patients and help them to keep the skin free from contaminants and infections. The skin barrier is a thin film used to close the ostomy bags to prevent the leakage. It is majorly used to avert fecal waste from patient’s body and contain liquid and semiliquid stool. Furthermore, it helps protect patients from exposure, tissue damage, and odor. A skin barrier film is designed to manage fecal inconsistence in bedridden patients, and has proven to be effective even in prevention & infection control. It provides safer patient outcomes and augment ease of nursing. The devices help in attachment of ostomy bags to the individual’s body to maintain incontinence. These skin barriers are available in two different shapes, including flat and convex.

Surge in availability of technological advanced devices for fecal management, rise in geriatric population, and surge in fecal inconsistency related disorders are the major factors driving the market growth of skin barriers market. Furthermore, increase in awareness toward the availability of these devices accompanied with launch of new devices addressing the unmet medical needs significantly contribute toward the market growth. However, lack of trained professionals and patient’s discomfort in using these devices hinder the growth of market. On the contrary, development of the healthcare industry and increase in R&D activities undertaken by key players towards skin barrier functions are expected to boost the market growth during the forecast period.

Depending on shape, the flat-shaped segment dominated the skin barrier market in 2018, and is anticipated to maintain its dominance during the forecast period. This is attributed to increase in usage of flat-shaped skin barriers for the attachment to ostomy pouches in hospitals, clinics, and even home care for management of fecal inconsistence in adults. As the name signifies, flat-shaped skin barriers are flat, which are integrated with beige floating flange. These thin films are used in the ostomy bags to prevent leakage. They are designed to be used with any new drainable, closed, or urostomy pouch with same flange size. These barriers are not made with the natural rubber latex. It is widely used by bedridden patients, elderly people, and individuals suffering from irritable bowel disease.

On the basis of surgery type, the colostomy segment accounted for the majority of skin barrier market share in 2018, and is anticipated to grow at the fastest rate during the forecast period, owing to the fact that these are the most performed surgeries to prevent incontinence. North America accounted for the majority of the market share in 2018, and is anticipated to continue this trend during the forecast period. Ongoing R&D activities for introduction of novel bowel management devices for fecal management is the major trend in the North America skin barriers market. Rise in geriatric population in this region further contributes to the market growth. Asia-Pacific is growing at a significant CAGR owing to increase in per capita income in many countries, rise in government initiatives for the improvement of the healthcare sector, and surge in focus of leading manufacturers on expanding their geographical presence in emerging Asia-Pacific countries to capture potential growth opportunities in the market. Moreover, rise in demand for these products alarming increase in prevalence of irritable bowel syndrome fuels the skin barrier market growth.

The key players operating in the skin barriers market include 3M Company, B. Braun Melsungen AG, Coloplast Corp, ConvaTec Group PLC, Cymed Ostomy Pouching Systems, Hollister Inc., Marlen Manufacturing & Development Co., Nu-Hope Laboratories, Inc., Safe n’ Simple Medical, and Torbot Group, Inc.

Key Findings Of The Study

By surgery type, the colostomy segment was the highest contributor to the market, with $364.8 million in 2018, and is expected to continue the trend throughout the forecast period.
On the basis of shape, the flat segment is expected to grow at a CAGR of 4.2%.
Region wise, North America was the major shareholder and accounted for the highest share of 36% in 2018.
Asia-Pacific is expected to grow at a CAGR of 4.6% during the forecast period.
Note: Product cover images may vary from those shown
  • 3M Company
  • B. Braun Melsungen AG
  • Coloplast Corp
  • ConvaTec Group PLC
  • Cymed Ostomy Pouching Systems
  • Hollister Inc.
  • Marlen Manufacturing & Development Co.
  • Nu-Hope Laboratories Inc.
  • Safe n’ Simple Medical
  • Torbot Group Inc
Note: Product cover images may vary from those shown

The analyst offers exhaustive research and analysis based on a wide variety of factual inputs, which largely include interviews with industry participants, reliable statistics, and regional intelligence. The in-house industry experts play an instrumental role in designing analytic tools and models, tailored to the requirements of a particular industry segment. The primary research efforts include reaching out participants through mail, tele-conversations, referrals, professional networks, and face-to-face interactions.

They are also in professional corporate relations with various companies that allow them greater flexibility for reaching out to industry participants and commentators for interviews and discussions.

They also refer to a broad array of industry sources for their secondary research, which typically include; however, not limited to:

  • Company SEC filings, annual reports, company websites, broker & financial reports, and investor presentations for competitive scenario and shape of the industry
  • Scientific and technical writings for product information and related preemptions
  • Regional government and statistical databases for macro analysis
  • Authentic news articles and other related releases for market evaluation
  • Internal and external proprietary databases, key market indicators, and relevant press releases for market estimates and forecast

Furthermore, the accuracy of the data will be analyzed and validated by conducting additional primaries with various industry experts and KOLs. They also provide robust post-sales support to clients.

Loading
LOADING...